-The Hindu Unless a deeper, institutional change is ushered in to break the nexus between drug companies and the regulatory regime, Indians consuming drugs may be exposing themselves to serious risks Even before I walked into the Mayflower Hotel in the heart of Washington on a crisp autumn afternoon to meet Dinesh Thakur, whistle-blower and former director of India-based pharmaceutical giant Ranbaxy, I had a hunch that this conversation would spark some...
More »SEARCH RESULT
Medicines to get lot cheaper under new drug price policy -Soma Das
-The Economic Times NEW DELHI: Getting better is getting cheaper. The new drug price policy, the first after 18 years and expected to fully come into effect over the next six months, will reduce average middle class household spend on medicines by over 20%. For some crucial medicines, savings could be as much as 50% or more. The drug price regulator is crunching numbers to measure the impact of the new pricing...
More »A lifeline that rural India cannot do without -Raman Kataria and Yogesh Jain
-The Hindu The huge deficit in blood availability outside urban centres must jolt the government into legalising unbanked blood supply Twenty-year-old Putul, living in a village 70 km from a district headquarters town in Chhattisgarh, had been in labour for two days and a night. It was her first pregnancy. In order to hasten labour, the local quack administered several injections that increased her uterine contractions. Forty hours after the onset of...
More »Delivery deferred-Aarti Dhar
-The Hindu Health activists remind the Prime Minister of his last year's promise of free medication which will fulfil people's right to essential medicines Last year during his Independence Day speech from the ramparts of the Red Fort, Prime Minister Manmohan Singh had announced free distribution of medicines through government hospitals and health centres. One year down the line, however, the promise is far from being fulfilled and the declaration has made...
More »Drug price policy under SC glare
-The Telegraph New Delhi: The Supreme Court today ticked off the government for "dilly dallying" on an affordable drug pricing policy, following a petition that said the delay was aimed at pushing through suggestions of the powerful manufacturers' lobby. A bench of Justices G.S. Singhvi and Gopala Gowda asked the Centre to respond within six weeks. The All India Drug Action Network (AIDAN) had filed the application saying the government was delaying a...
More »